Trade Summary

3 days ago, Congleton Jon, serving as Chief Executive Officer at Mineralys Therapeutics, Inc. (MLYS), sold 10,700 shares at $27.24 per share, for a total transaction value of $291,441.25. Following this transaction, Congleton Jon now holds 603,621 shares of MLYS.

This sale represents a 1.74% decrease in Congleton Jon's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 13, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 (accepted Jul 15, 8:58 PM ET), 3 days after the trade was made.

Mineralys Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.